Indeed, numerous reports have described overexpression, hyperphosphorylation and/or elevated activity of FAK in a variety of human cancers, including sarcomas, astrocytomas and carcinomas of the breast, colon, thyroid, prostate, oral cavity, liver, stomach and ovary [1]. The gene discussed is PTK2; the disease is cancer.